Literature DB >> 11324427

Panax notoginseng saponins attenuated cisplatin-induced nephrotoxicity.

S J Liu1, S W Zhou.   

Abstract

AIM: To study protective effects of Panax notoginseng saponins (PnS) against cisplatin-nephrotoxicity.
METHODS: Cisplatin-induced nephrotoxicity in mice in vivo, and primary culture of rabbit proximal tubular cells (PTC) in vitro were established. Blood urea nitrogen, serum creatinine, cell viability, DNA interstrand cross-link, DNA-protein cross-link, and cytosolic free [Ca2+]i were assayed with diacetyl monoxime, alkaline picrate, trypan blue, ethidium bromide binding, 125I-postlabelling, and Fur 2-AM, respectively.
RESULTS: With pretreatment for 2 d in mice, PnS 100 and 200 mg.kg-1.d-1 suppressed cisplatin-induced high blood urea nitrogen level to 83% and 31%, and serum creatinine level to 86% and 42%, respectively (P < 0.01). Preincubated with PTC for 24 h, PnS 10 and 100 mg.L-1 inhibited cisplatin-induced decrease of cell viability from 78% to 81% (P < 0.05) and 89% (P < 0.01), respectively. PnS 10 and 100 mg.L-1 suppressed formations of DNA interstrand cross-link to 47% and 40%, DNA-protein interstrand cross-link to 77% and 42%, and cytosolic free [Ca2+]i overload in PTC to 70% and 63%, respectively. (P < 0.01).
CONCLUSION: PnS was a prophylactic for cisplatin-induced nephrotoxicity, and mechanisms were relevant to the effects that PnS reduced cisplatin-induced cytosolic free [Ca2+]i overload, and formations of DNA interstrand cross-link and DNA-protein cross-link.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11324427

Source DB:  PubMed          Journal:  Acta Pharmacol Sin        ISSN: 1671-4083            Impact factor:   6.150


  8 in total

1.  Successful treatment of canine open cervix-pyometra with Yun-Nan-Pai-Yao, a Chinese herbal preparation.

Authors:  B Salgado; R Paramo; H Sumano
Journal:  Vet Res Commun       Date:  2007-05       Impact factor: 2.459

2.  Panax notoginseng saponins attenuates cisplatin-induced nephrotoxicity via inhibiting the mitochondrial pathway of apoptosis.

Authors:  Xinwen Liu; Zhenguang Huang; Xiaoqin Zou; Yufang Yang; Yue Qiu; Yan Wen
Journal:  Int J Clin Exp Pathol       Date:  2014-11-15

3.  New dammarane-type triterpenoid saponins from Panax notoginseng saponins.

Authors:  Qian Li; Mingrui Yuan; Xiaohui Li; Jinyu Li; Ming Xu; Di Wei; Desong Wu; Jinfu Wan; Shuangxi Mei; Tao Cui; Jingkun Wang; Zhaoyun Zhu
Journal:  J Ginseng Res       Date:  2018-12-13       Impact factor: 6.060

Review 4.  Jamaican bitter yam sapogenin: potential mechanisms of action in diabetes.

Authors:  Felix O Omoruyi
Journal:  Plant Foods Hum Nutr       Date:  2008-07-02       Impact factor: 3.921

5.  Association of prescribed Chinese herbal medicine use with risk of end-stage renal disease in patients with chronic kidney disease.

Authors:  Ming-Yen Lin; Yi-Wen Chiu; Jung-San Chang; Hung-Lung Lin; Charles Tzu-Chi Lee; Guei-Fen Chiu; Mei-Chuan Kuo; Ming-Tsang Wu; Hung-Chun Chen; Shang-Jyh Hwang
Journal:  Kidney Int       Date:  2015-08-05       Impact factor: 10.612

6.  Panax notoginseng saponins mitigate cisplatin induced nephrotoxicity by inducing mitophagy via HIF-1α.

Authors:  Xueyan Liang; Yufang Yang; Zhenguang Huang; Jinling Zhou; Yue'e Li; Xiaobin Zhong
Journal:  Oncotarget       Date:  2017-08-03

7.  5,6-Didehydroginsenosides from the roots of Panax notoginseng.

Authors:  Jian-Bo Wan; Qing-Wen Zhang; Si-Jia Hong; Jia Guan; Wen-Cai Ye; Shao-Ping Li; Ming-Yuen Simon Lee; Yi-Tao Wang
Journal:  Molecules       Date:  2010-11-11       Impact factor: 4.411

8.  Panax notoginseng saponins alleviate skeletal muscle insulin resistance by regulating the IRS1-PI3K-AKT signaling pathway and GLUT4 expression.

Authors:  Xuan Guo; Wen Sun; Guangbin Luo; Lili Wu; Guangyuan Xu; Dan Hou; Yi Hou; Xiangyu Guo; Xiaohong Mu; Lingling Qin; Tonghua Liu
Journal:  FEBS Open Bio       Date:  2019-04-26       Impact factor: 2.693

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.